메뉴 건너뛰기




Volumn 24, Issue 9, 2003, Pages 594-601

Treatment of systemic mastocytosis;Traitement des mastocytoses systémiques

Author keywords

C kit; Cladribine; Cytarabine; Imatinib mesylate; Interferon; Mastocytosis

Indexed keywords

ALPHA INTERFERON; ANAHELP; ANAKIT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; AUTACOID; BISPHOSPHONIC ACID DERIVATIVE; BUDESONIDE; CETIRIZINE; CHYMOTRYPSIN; CLADRIBINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; CYTARABINE; ETOMIDATE; FAMOTIDINE; FEXOFENADINE; HEPARIN; HISTAMINE; HYDRALAZINE; IMATINIB; LEUKOTRIENE; METHOXSALEN; METHYLPREDNISOLONE; MIDAZOLAM; MIZOLASTINE; NEOMYCIN; PAROXETINE; PILOCARPINE; POLYMYXIN B; PROPOFOL; PROSTAGLANDIN; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RANITIDINE; RESERPINE; SALICYLIC ACID DERIVATIVE; SCOPOLAMINE; STEM CELL FACTOR; UNINDEXED DRUG;

EID: 0042876805     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00141-3     Document Type: Short Survey
Times cited : (14)

References (58)
  • 4
    • 0009013631 scopus 로고    scopus 로고
    • Somatic c-KIT-activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
    • Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, et al. Somatic c-KIT-activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-4.
    • (1996) Nat Genet , vol.12 , pp. 312-314
    • Longley, B.J.1    Tyrrell, L.2    Lu, S.Z.3    Ma, Y.S.4    Langley, K.5    Ding, T.G.6
  • 5
    • 0030814553 scopus 로고    scopus 로고
    • Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis
    • Horny HP, Ruck P, Krober SM, Kaiserling E. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis. Histol Histopathol 1997;12:1081-9.
    • (1997) Histol Histopathol , vol.12 , pp. 1081-1089
    • Horny, H.P.1    Ruck, P.2    Krober, S.M.3    Kaiserling, E.4
  • 7
    • 0012083046 scopus 로고
    • Staging of systemic mastocytosis: Bone marrow scintigraphy, cytology and bone scan, a preliminary study
    • Caillat-Vigneron N, Lortholary O, Guillevin L, Raphaël M, Casassus P. Staging of systemic mastocytosis: bone marrow scintigraphy, cytology and bone scan, a preliminary study [abstract]. Blood 1994;84(suppl 1):2504.
    • (1994) Blood , vol.84 , Issue.SUPPL. 1 , pp. 2504
    • Caillat-Vigneron, N.1    Lortholary, O.2    Guillevin, L.3    Raphaël, M.4    Casassus, P.5
  • 8
    • 13044305857 scopus 로고    scopus 로고
    • Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis
    • Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrell L, Lu SZ, et al. Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999;96:1609-14.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 1609-1614
    • Longley, B.J.1    Metcalfe, D.D.2    Tharp, M.3    Wang, X.4    Tyrell, L.5    Lu, S.Z.6
  • 9
    • 0037097036 scopus 로고    scopus 로고
    • Systemic mastocytosis and recurrent anaphylactic shock
    • Koide T, Nakajima T, Makifuchi T, Fukuhara N. Systemic mastocytosis and recurrent anaphylactic shock. Lancet 2002;359:2084.
    • (2002) Lancet , vol.359 , pp. 2084
    • Koide, T.1    Nakajima, T.2    Makifuchi, T.3    Fukuhara, N.4
  • 10
    • 0000948242 scopus 로고
    • Anaesthetic management of systemic mastocytosis: Experience with 42 cases
    • Parris WCV, Scott HW, Smith BE. Anaesthetic management of systemic mastocytosis: experience with 42 cases. Anaesth Analg 1986;65:S117.
    • (1986) Anaesth Analg , vol.65
    • Parris, W.C.V.1    Scott, H.W.2    Smith, B.E.3
  • 12
    • 0018687287 scopus 로고
    • Oral disodium cromoglycate in the treatment of systemic mastocytosis
    • Solter NS, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-9.
    • (1979) N Engl J Med , vol.301 , pp. 465-469
    • Solter, N.S.1    Austen, K.F.2    Wasserman, S.I.3
  • 13
    • 0019843315 scopus 로고
    • Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate
    • Czarnetzki BM, Behrendt H. Urticaria pigmentosa: Clinical picture and response to oral disodium cromoglycate. Br J Dermatol 1981;105:563-7.
    • (1981) Br J Dermatol , vol.105 , pp. 563-567
    • Czarnetzki, B.M.1    Behrendt, H.2
  • 14
  • 17
    • 0018957223 scopus 로고
    • The effect of cimetidine and propentheline on the symptoms of a patient with systemic mastocytosis
    • Achord JL, Langford H. The effect of cimetidine and propentheline on the symptoms of a patient with systemic mastocytosis. Am J Med 1980;69:610-4.
    • (1980) Am J Med , vol.69 , pp. 610-614
    • Achord, J.L.1    Langford, H.2
  • 18
    • 0021907622 scopus 로고
    • Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: Results of a double blind trial
    • Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double blind trial. Am J Med 1985;78:9-14.
    • (1985) Am J Med , vol.78 , pp. 9-14
    • Frieri, M.1    Alling, D.W.2    Metcalfe, D.D.3
  • 19
    • 0018769542 scopus 로고
    • Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis
    • Hirschowitz BI, Groarke JF. Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 1979;90:769-71.
    • (1979) Ann Intern Med , vol.90 , pp. 769-771
    • Hirschowitz, B.I.1    Groarke, J.F.2
  • 20
    • 0031398769 scopus 로고    scopus 로고
    • Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis
    • Kurosawa M, Kanbe N, Yamashita T, Miyachi Y. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. J Allergy Clin Immunol 1997;100:S25-32.
    • (1997) J Allergy Clin Immunol , vol.100
    • Kurosawa, M.1    Kanbe, N.2    Yamashita, T.3    Miyachi, Y.4
  • 21
    • 0029848806 scopus 로고    scopus 로고
    • The tolerability and safety profile of famotidine
    • Howden CW, Tytgat GNJ. The tolerability and safety profile of famotidine. Clin Ther 1996;18:36-54.
    • (1996) Clin Ther , vol.18 , pp. 36-54
    • Howden, C.W.1    Tytgat, G.N.J.2
  • 22
    • 0027241041 scopus 로고
    • Safety issues relating to long-term treatment with histamine H2-receptor antagonists
    • Sabesin SM. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Aliment Pharmacol Ther 1993;7(suppl 2):35-40.
    • (1993) Aliment Pharmacol Ther , vol.7 , Issue.SUPPL. 2 , pp. 35-40
    • Sabesin, S.M.1
  • 23
    • 0020660043 scopus 로고
    • A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa
    • Czarnetzki BM. A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 1983;166:44-7.
    • (1983) Dermatologica , vol.166 , pp. 44-47
    • Czarnetzki, B.M.1
  • 25
    • 0024355259 scopus 로고
    • A double-blind., placebo-controlled, cross-over trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis
    • Kettelhut BV, Berkebile C, Bradley D, Metcalfe DD. A double-blind., placebo-controlled, cross-over trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. J Allergy Clin Immunol 1989;83:866-70.
    • (1989) J Allergy Clin Immunol , vol.83 , pp. 866-870
    • Kettelhut, B.V.1    Berkebile, C.2    Bradley, D.3    Metcalfe, D.D.4
  • 26
    • 0023260179 scopus 로고
    • Osteopenia in systemic mastocytosis: Natural history and responses to treatment with inhibitors of bone resorption
    • Cundy T, Beneton MNC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.
    • (1987) Bone , vol.8 , pp. 149-155
    • Cundy, T.1    Beneton, M.N.C.2    Darby, A.J.3    Marshall, W.J.4    Kanis, J.A.5
  • 27
    • 0030841035 scopus 로고    scopus 로고
    • The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis
    • Marshall A, Kavanagh RT, Crisp AJ. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 1997;39:393-6.
    • (1997) Br J Rheumatol , vol.39 , pp. 393-396
    • Marshall, A.1    Kavanagh, R.T.2    Crisp, A.J.3
  • 28
    • 0036128440 scopus 로고    scopus 로고
    • Osteoporosis and bone marrow mastocytosis: Dissociation of skeletal responses and mast cell activity during long-term bisphophonate therapy
    • Brumsen C, Hamdy NAT, Papapoulos SE. Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphophonate therapy. J Bone miner Res 2002;17:567-9.
    • (2002) J Bone Miner Res , vol.17 , pp. 567-569
    • Brumsen, C.1    Hamdy, N.A.T.2    Papapoulos, S.E.3
  • 29
    • 0026695463 scopus 로고
    • Radiation therapy in a case of systemic mastocytosis: Evaluation of histamine levels and mucosal effects
    • Janjan NA, Conway P, Ludberg J, Derfus G. Radiation therapy in a case of systemic mastocytosis: evaluation of histamine levels and mucosal effects. Am J Clin Oncol 1992;15:337-9.
    • (1992) Am J Clin Oncol , vol.15 , pp. 337-339
    • Janjan, N.A.1    Conway, P.2    Ludberg, J.3    Derfus, G.4
  • 32
    • 0030742614 scopus 로고    scopus 로고
    • Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis
    • Godt O, Proksch E, Streit V, Christophers E. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997;195:35-9.
    • (1997) Dermatology , vol.195 , pp. 35-39
    • Godt, O.1    Proksch, E.2    Streit, V.3    Christophers, E.4
  • 33
    • 0021237539 scopus 로고
    • Reponse of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations
    • Kolde G, Frosch PJ, Czametzki BM. Reponse of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural and biochemical investigations. J Invest Dermatol 1984;83:175-8.
    • (1984) J Invest Dermatol , vol.83 , pp. 175-178
    • Kolde, G.1    Frosch, P.J.2    Czametzki, B.M.3
  • 35
    • 0025921183 scopus 로고
    • The treatment of mastocytosis: An overview
    • Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 1991;96:55S-9S.
    • (1991) J Invest Dermatol , vol.96
    • Metcalfe, D.D.1
  • 36
    • 0025896624 scopus 로고
    • Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: A preliminary study
    • Friedman BS, Metcalfe DD. Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study. Clin Exp Allergy 1991;21:183-8.
    • (1991) Clin Exp Allergy , vol.21 , pp. 183-188
    • Friedman, B.S.1    Metcalfe, D.D.2
  • 38
    • 0030870541 scopus 로고    scopus 로고
    • Oral budesonide is as effective as prednisolone in active Crohn's disease
    • Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG, the global budesonide study group. Oral budesonide is as effective as prednisolone in active Crohn's disease. Gut 1997;41:209-14.
    • (1997) Gut , vol.41 , pp. 209-214
    • Campieri, M.1    Ferguson, A.2    Doe, W.3    Persson, T.4    Nilsson, L.G.5
  • 42
    • 0025854383 scopus 로고
    • Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients
    • Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann Intern Med 1991;114:532-8.
    • (1991) Ann Intern Med , vol.114 , pp. 532-538
    • Talpaz, M.1    Kantarjian, H.2    Kurzrock, R.3    Trujillo, J.M.4    Gutterman, J.U.5
  • 43
    • 0034353292 scopus 로고    scopus 로고
    • Effects of interferon-a2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis
    • Schernthaner GH, Spanblöchl E, Sperr WR, Sillaber C, Semper H, Jurecka W, et al. Effects of interferon-a2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis. Ann Hematol 2000;79:660-6.
    • (2000) Ann Hematol , vol.79 , pp. 660-666
    • Schernthaner, G.H.1    Spanblöchl, E.2    Sperr, W.R.3    Sillaber, C.4    Semper, H.5    Jurecka, W.6
  • 45
    • 0032539359 scopus 로고    scopus 로고
    • Interféron alpha et pamidronate: Une association intéressante dans le traitement des localisations osseuses de la mastocytose systémique
    • Brunel V, Tadrist Z, Cailleres T, Allegre T, Blanc AP. Interféron alpha et pamidronate: une association intéressante dans le traitement des localisations osseuses de la mastocytose systémique. Presse Méd 1998;18:64.
    • (1998) Presse Méd , vol.18 , pp. 64
    • Brunel, V.1    Tadrist, Z.2    Cailleres, T.3    Allegre, T.4    Blanc, A.P.5
  • 46
    • 0031870101 scopus 로고    scopus 로고
    • Systemic mastocytosis with extensive polypoid lesion in the intestines, successful treatment with interferon-α
    • Takasaki Y, Tsukasaki K, Jubashi T, Tomonaga M, Kamihira S, Makiyama K. Systemic mastocytosis with extensive polypoid lesion in the intestines, successful treatment with interferon-α. Intern Med 1998;37:484-8.
    • (1998) Intern Med , vol.37 , pp. 484-488
    • Takasaki, Y.1    Tsukasaki, K.2    Jubashi, T.3    Tomonaga, M.4    Kamihira, S.5    Makiyama, K.6
  • 47
    • 0031943841 scopus 로고    scopus 로고
    • Response of severe systemic mastocytosis to interferon alpha
    • Butterfield JH. Response of severe systemic mastocytosis to interferon alpha. Br j Dermatol 1998;138:489-95.
    • (1998) Br J Dermatol , vol.138 , pp. 489-495
    • Butterfield, J.H.1
  • 49
    • 0345772088 scopus 로고    scopus 로고
    • Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria
    • Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003;27:635-41.
    • (2003) Leuk Res , vol.27 , pp. 635-641
    • Valent, P.1    Akin, C.2    Sperr, W.R.3    Escribano, L.4    Arock, M.5    Horny, H.P.6
  • 50
    • 0036454699 scopus 로고    scopus 로고
    • Treatment of adult systemic mastocytosis with interferon-alpha: Results of a multicenter phase II trial on 20 patients
    • Casassus P, Caillat-Vigneron, Martin A, Simon J, Gallais V, Beaudry P, et al. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicenter phase II trial on 20 patients. Br J Hematol 2002;119:1-8.
    • (2002) Br J Hematol , vol.119 , pp. 1-8
    • Casassus, P.1    Caillat-Vigneron2    Martin, A.3    Simon, J.4    Gallais, V.5    Beaudry, P.6
  • 51
    • 0035797572 scopus 로고    scopus 로고
    • Paroxetine for the prevention of depression induced by interferon alpha
    • Kraus MR, Schafer A, Scheurlen M. Paroxetine for the prevention of depression induced by interferon alpha. N Engl J Med 2001;345:375-6.
    • (2001) N Engl J Med , vol.345 , pp. 375-376
    • Kraus, M.R.1    Schafer, A.2    Scheurlen, M.3
  • 52
    • 0345696854 scopus 로고    scopus 로고
    • Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
    • Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. N Engl J Med 1997;337:223-99.
    • (1997) N Engl J Med , vol.337 , pp. 223-299
    • Guilhot, F.1    Chastang, C.2    Michallet, M.3    Guerci, A.4    Harousseau, J.L.5    Maloisel, F.6
  • 53
    • 0036842301 scopus 로고    scopus 로고
    • Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma
    • Escribano L, De Oteyza PJ, Nunez R, Orfao A. Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma. Leuk Res 2002;26:1043-6.
    • (2002) Leuk Res , vol.26 , pp. 1043-1046
    • Escribano, L.1    De Oteyza, P.J.2    Nunez, R.3    Orfao, A.4
  • 54
    • 0033564769 scopus 로고    scopus 로고
    • Cladribine activity in adult langerhans-cell histiocytosis
    • Saven A, Burian C. Cladribine activity in adult langerhans-cell histiocytosis. Blood 1999;15(93):4125-30.
    • (1999) Blood , vol.15 , Issue.93 , pp. 4125-4130
    • Saven, A.1    Burian, C.2
  • 57
    • 0036493872 scopus 로고    scopus 로고
    • The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutation show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations
    • Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, et al. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutation show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002;99:1741-4.
    • (2002) Blood , vol.99 , pp. 1741-1744
    • Ma, Y.1    Zeng, S.2    Metcalfe, D.D.3    Akin, C.4    Dimitrijevic, S.5    Butterfield, J.H.6
  • 58
    • 0344987886 scopus 로고    scopus 로고
    • The effect of tyrosine kinase inhibitor ST1571 on the kinase activity of wild type and various mutated c-kit receptor found in mast cells neoplasms
    • Zermati Y, de Sepulveda P, Létard F, Kersual J, Castéran N, Gorochov G, et al. The effect of tyrosine kinase inhibitor ST1571 on the kinase activity of wild type and various mutated c-kit receptor found in mast cells neoplasms. Oncogene 2003;22:660-4.
    • (2003) Oncogene , vol.22 , pp. 660-664
    • Zermati, Y.1    De Sepulveda, P.2    Létard, F.3    Kersual, J.4    Castéran, N.5    Gorochov, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.